Dr. Hamat, Principal Investigator
Dr. Hamat serves as the Principal Investigator at Integrity Advanced Therapeutics (IAT), leading all clinical research initiatives focused on gastroenterology and liver diseases.
With extensive clinical expertise and a strong background in both patient care and research, Dr. Hamat oversees the scientific integrity, patient safety, and regulatory compliance of all trials conducted at the site.
A distinguished gastroenterologist, Dr. Hamat brings a passion for innovation and a deep commitment to translating research into real-world treatments that enhance patient outcomes.
Under his leadership, IAT conducts Phase I–IV trials across a wide range of gastrointestinal and hepatic conditions, including Inflammatory Bowel Disease (IBD), functional GI disorders, NAFLD, and liver fibrosis.
Dr. Hamat is known for his patient-first philosophy, scientific rigor, and collaborative spirit, making him an integral leader in advancing new therapies for complex digestive and liver diseases.
Skills & Qualifications
- Inflammatory Bowel Disease (Crohn’s Disease, Ulcerative Colitis)
- Gastroesophageal Reflux Disease (GERD)
- Functional Gastrointestinal Disorders (Gastroparesis, Dyspepsia)
- Liver Disease Research (NAFLD, Hepatitis, Cirrhosis)
- Clinical Trial Protocol Development and Execution
- Regulatory Compliance (FDA, ICH-GCP)
Professional Experience:
With over 15 years of experience in gastroenterology clinical practice and research, Dr. Hamat serves as a seasoned Principal Investigator for multiple Phase II–IV clinical trials in gastrointestinal and hepatology domains. He brings deep expertise in managing multi-site studies, ensuring scientific integrity, regulatory compliance, and the highest standards of patient safety. Dr. Hamat is deeply committed to bridging the gap between clinical care and research innovation, with a focus on advancing treatments that improve outcomes for patients with complex digestive and liver conditions.
Expertise
- 15+ years of experience in gastroenterology clinical practice and research
- Principal Investigator for multiple Phase II–IV gastrointestinal and hepatology clinical trials
- Experienced in managing multi-site studies, ensuring both scientific quality and patient safety
- Dedicated to integrating clinical care with research innovation
- Inflammatory Bowel Disease (IBD)
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Advanced Endoscopy and Diagnostics
- Hepatitis B & C Management
- Clinical Trials in Hepatology and Gastroenterology